ANDA 77689, held by Rising Pharmaceuticals. Ciprofloxacin Hydrochloride.
As of Nov 21, 2026, ANDA 77689 (Ciprofloxacin Hydrochloride), held by Rising Pharmaceuticals, was first approved by FDA on Dec 13, 2006, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ciprofloxacin HydrochlorideEQ 0.3% BASE · solution/drops;ophthalmic | Ciprofloxacin Hydrochloride | Rx |
| Jun 2, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Dec 13, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters